Percutaneous cardiopulmonary bypass for therapy resistant cardiac arrest from digoxin overdose.
A 79-year 65 kg male called the ambulance service 4 h after ingestion of 100 tablets of digoxin 0.1 mg complaining of nausea and vomiting. The ECG showed an idioventricular escape rhythm with a heart rate of 30/min. After 0.5 mg atropine, heart rate increased to 80/min. Soon after admission to the emergency department, the patient developed electromechanical dissociation. Due to persistent cardiac arrest, percutaneous cardiopulmonary bypass was started, and the ECG rhythm changed to ventricular fibrillation. Several attempts to terminate ventricular fibrillation by electrical defibrillation failed. Fifty-eight minutes after cardiac arrest, antidigoxin-Fab was administered and 1 h 25 min after cardiac arrest, ventricular fibrillation was terminated by the tenth electrical defibrillation attempt. Initially, the patient's overall status improved over the next 2 days, but then he developed a severe adult respiratory distress syndrome and died of unresponsive septic shock 12 days after ingestion of digoxin. This case demonstrates that percutaneous cardiopulmonary bypass may provide support in patients with cardiac arrest due to massive digoxin overdose. This temporary support can maintain adequate tissue perfusion during the time required for drug neutralization in order to achieve successful defibrillation. Percutaneous cardiopulmonary bypass should be considered in patients with severe, but temporary cardiac dysfunction due to a life-threatening drug overdose.
Behringer
W
W
Department of Emergency Medicine, University of Vienna, Medical School, Austria. wilhelm.behringer@akh-wien.ac.at
Sterz
F
F
Domanovits
H
H
Schoerkhuber
W
W
Holzer
M
M
Foedinger
M
M
Laggner
A N
AN
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D002315:Cardiopulmonary Bypass; D004077:Digoxin / Q000009:adverse effects*; D062787:Drug Overdose / Q000150:complications*; D004554:Electric Countershock; D017809:Fatal Outcome; D006323:Heart Arrest / Q000139:chemically induced* / Q000601:surgery* / Q000628:therapy; D006801:Humans; D008297:Male; D019233:Retreatment
D000889:Anti-Arrhythmia Agents; D004077:Digoxin